Margareta Spjut
Atle Fund Management Ab
Assets Managed
$309.685M
Holdings
39
Last Quarter
2026 - Q1
Filed Date
5d ago
Growth Rate
-1.19%(2Q avg: 530.52%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Atle Fund Management Ab's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 39 positions.
Assets under management
The assets under management (AUM) of Atle Fund Management Ab over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 309.685M in assets, with a quarterly growth rate of -1.19% and a 2-quarter average growth rate of 530.52%. The portfolio is managed by Margareta Spjut, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
LLY Eli Lilly & Co
| 8.67% | $26.845M 39,722 shares@ $675.84 avg price | Increased 27.59% |
MRK Merck & Co. Inc.
| 7.41% | $22.917M 33,853 shares@ $676.97 avg price | Decreased -82.7% |
TMO Thermo Fisher Scientific Inc
| 4.67% | $14.45M 22,986 shares@ $628.65 avg price | Decreased -23.16% |
BGNE Beigene Ltd-adr
| 3.92% | $12.137M 41,717 shares@ $290.95 avg price | Increased 3.18% |
JNJ Johnson & Johnson
| 3.86% | $11.943M 92,377 shares@ $129.29 avg price | New Position |
BBIO Bridgebio Pharma Inc
| 3.85% | $11.893M 111,363 shares@ $106.8 avg price | Decreased -21.18% |
VRTX Vertex Pharmaceuticals Inc
| 3.61% | $11.168M 22,984 shares@ $485.91 avg price | |
ABBV Abbvie Inc
| 3.36% | $10.386M 108,181 shares@ $96.01 avg price | |
SYK Stryker Corp
| 3.1% | $9.58M 26,835 shares@ $356.99 avg price | |
ISRG Intuitive Surgical Inc
| 3.05% | $9.445M 70,851 shares@ $133.31 avg price | Increased 217.41% |
1-10 of 39